New cytogenetic abnormalities are frequent in AML and MDS relapsing after allogeneic hematopoietic cell transplantation (HCT).

被引:0
|
作者
Pollyea, Daniel A.
Artz, Andrew S.
Stock, Wendy
Daugherty, Christopher
Godley, Lucy
Odenike, Olatoyosi M.
Rich, Elizabeth
Smith, Sonali M.
Zimmerman, Todd
Zhang, Yanming
Huo, Dezheng
Larson, Richard
Van Besien, Koen
机构
[1] Cook Cty Hosp, Chicago, IL USA
[2] Univ Chicago Hosp, Chicago, IL 60637 USA
关键词
D O I
10.1182/blood.V108.11.3675.3675
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3675
引用
收藏
页码:1050A / 1050A
页数:1
相关论文
共 50 条
  • [21] Thymoglobulin after Matched Unrelated Hematopoietic Stem Cell Transplantation (HCT) in AML/MDS Results in Improved Outcomes Comparable to Matched Related HCT
    Khaled, Yasser
    Patel, Rushang D.
    Ahmed, Wesam
    Mori, Shahram
    Solh, Melhem
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S329 - S330
  • [22] Allogeneic hematopoietic cell transplantation (HCT) with a HLA-mismatched donor for patients with AML or MDS - results of a single center retrospective analysis
    Dorn, C.
    Haen, S. P.
    Faul, C.
    Vogel, W.
    Kanz, L.
    Bethge, W. A.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 134 - 135
  • [23] Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation
    Pollyea, D. A.
    Artz, A. S.
    Stock, W.
    Daugherty, C.
    Godley, L.
    Odenike, O. M.
    Rich, E.
    Smith, S. M.
    Zimmerman, T.
    Zhang, Y.
    Huo, D.
    Larson, R.
    van Besien, K.
    BONE MARROW TRANSPLANTATION, 2007, 40 (11) : 1027 - 1032
  • [24] Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation
    D A Pollyea
    A S Artz
    W Stock
    C Daugherty
    L Godley
    O M Odenike
    E Rich
    S M Smith
    T Zimmerman
    Y Zhang
    D Huo
    R Larson
    K van Besien
    Bone Marrow Transplantation, 2007, 40 : 1027 - 1032
  • [25] The Hematopoietic Cell Transplant-Co-Morbidity Index (HCT-CI) Predicts Outcomes After T Cell Depleted (TCD) Allogeneic HCT For AML and MDS
    Ratan, Ravin
    Ceberio, Izaskun
    Hilden, Patrick
    Devlin, Sean M.
    Malloy, Molly A.
    Barker, Juliet N.
    Castro-Malaspina, Hugo
    Jakubowski, Ann A.
    Koehne, Guenther
    Papadopoulos, Esperanza B.
    Ponce, Doris M.
    Sauter, Craig S.
    van den Brink, Marcel R. M.
    Young, James W.
    O'Reilly, Richard J.
    Giralt, Sergio
    Goldberg, Jenna D.
    Perales, Miguel-Angel
    BLOOD, 2013, 122 (21)
  • [26] Allogeneic hematopoietic stem cell transplantation for intermediate cytogenetic risk AML in first CR
    Imahashi, N.
    Suzuki, R.
    Fukuda, T.
    Kakihana, K.
    Kanamori, H.
    Eto, T.
    Mori, T.
    Kobayashi, N.
    Iwato, K.
    Sakura, T.
    Ikegame, K.
    Kurokawa, M.
    Kondo, T.
    Iida, H.
    Sakamaki, H.
    Tanaka, J.
    Kawa, K.
    Morishima, Y.
    Atsuta, Y.
    Miyamura, K.
    BONE MARROW TRANSPLANTATION, 2013, 48 (01) : 56 - 62
  • [27] Allogeneic hematopoietic stem cell transplantation for intermediate cytogenetic risk AML in first CR
    N Imahashi
    R Suzuki
    T Fukuda
    K Kakihana
    H Kanamori
    T Eto
    T Mori
    N Kobayashi
    K Iwato
    T Sakura
    K Ikegame
    M Kurokawa
    T Kondo
    H Iida
    H Sakamaki
    J Tanaka
    K Kawa
    Y Morishima
    Y Atsuta
    K Miyamura
    Bone Marrow Transplantation, 2013, 48 : 56 - 62
  • [28] Allogeneic Hematopoietic Stem Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML) Not in First Remission
    Sweet, Kendra L.
    Lancet, Jeffrey E.
    Hillgruber, Ryan
    Melody, Megan
    Llishi, Amina
    Perkins, Janelle
    Fernandez, Hugo F.
    Field, Teresa
    BLOOD, 2015, 126 (23)
  • [29] Severe metabolic abnormalities after allogeneic hematopoietic cell transplantation
    J-H Lee
    S-J Choi
    J-H Lee
    S-E Kim
    M Seol
    Y-S Lee
    J-S Lee
    W-K Kim
    K-H Lee
    Bone Marrow Transplantation, 2005, 35 : 63 - 69
  • [30] Severe metabolic abnormalities after allogeneic hematopoietic cell transplantation
    Lee, JH
    Choi, SJ
    Lee, JH
    Kim, SE
    Seol, M
    Lee, YS
    Lee, JS
    Kim, WK
    Lee, KH
    BONE MARROW TRANSPLANTATION, 2005, 35 (01) : 63 - 69